• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过放射性核素静脉造影功能分析对患有上腔静脉综合征的患者进行随访。

Follow-up of patients with superior vena cava syndrome by functional analysis of radionuclide venography.

作者信息

Mahmud A M, Teshima T, Isawa T, Miki M, Horikoshi M, Yanagimachi T, Nukiwa T

机构信息

Department of Respiratory Oncology and Molecular Medicine, Tohoku University, Sendai, Japan.

出版信息

Nucl Med Commun. 1998 May;19(5):417-26. doi: 10.1097/00006231-199805000-00003.

DOI:10.1097/00006231-199805000-00003
PMID:9853330
Abstract

In addition to imaging, radionuclide venography can be used for studying haemodynamic changes in superior vena cava syndrome (SVCS) by using the indices of transit time (TT), time of half peak count (TH) and peak count ratio (PC ratio). The objective of this study was to examine the utility of applying these indices, alongside images, in the post-therapy assessment of SVCS patients. Radionuclide venography was performed twice on 36 patients with SVCS due to thoracic malignancies, 29 of whom received specific anti-cancer therapy between the two studies (Group I); the other 7 did not receive such therapy (Group II). On the images, 12 patients in Group I showed improvement, one a deterioration and 16 no change; in Group II, 4 showed a deterioration and 3 no change. Using the indices, nearly all patients in Group I had decreased post-therapy values indicating haemodynamic improvement. A significant difference was seen between the mean (+/- S.E.) pre- and post-therapy values for TT (pre vs post: 6.2 +/- 0.7 vs 2.7 +/- 0.3 s) and TH (pre vs post: 16.9 +/- 2.3 vs 7.9 +/- 0.8 s) (P < 0.001). Although the PC ratio showed a non-significant decrement, it related to the status of collateral change. The above indices provide clinically valuable information about the haemodynamic status of patients with SVCS and can be used for their post-therapy evaluation.

摘要

除影像学检查外,放射性核素静脉造影可通过使用通过时间(TT)、半峰值计数时间(TH)和峰值计数比(PC比)等指标来研究上腔静脉综合征(SVCS)的血流动力学变化。本研究的目的是检验在SVCS患者的治疗后评估中应用这些指标并结合图像的效用。对36例因胸部恶性肿瘤导致SVCS的患者进行了两次放射性核素静脉造影,其中29例在两次检查之间接受了特异性抗癌治疗(I组);另外7例未接受此类治疗(II组)。在图像上,I组12例患者显示改善,1例恶化,16例无变化;II组中,4例恶化,3例无变化。使用这些指标,I组几乎所有患者治疗后的值均降低,表明血流动力学改善。TT(治疗前与治疗后:6.2±0.7 vs 2.7±0.3秒)和TH(治疗前与治疗后:16.9±2.3 vs 7.9±0.8秒)的治疗前和治疗后平均(±标准误)值之间存在显著差异(P<0.001)。尽管PC比显示出不显著的下降,但它与侧支循环变化的状态有关。上述指标提供了关于SVCS患者血流动力学状态的临床有价值信息,可用于他们的治疗后评估。

相似文献

1
Follow-up of patients with superior vena cava syndrome by functional analysis of radionuclide venography.通过放射性核素静脉造影功能分析对患有上腔静脉综合征的患者进行随访。
Nucl Med Commun. 1998 May;19(5):417-26. doi: 10.1097/00006231-199805000-00003.
2
Radionuclide venography and its functional analysis in superior vena cava syndrome.
J Nucl Med. 1996 Sep;37(9):1460-4.
3
Shunt between right subclavian vein and the left heart in superior vena cava obstruction due to lung cancer.肺癌导致上腔静脉阻塞时右锁骨下静脉与左心之间的分流。
Clin Nucl Med. 1990 Apr;15(4):251-3. doi: 10.1097/00003072-199004000-00009.
4
Radionuclide venography in the evaluation of superior vena cava syndrome.
Clin Nucl Med. 1981 Apr;6(4):177-83. doi: 10.1097/00003072-198104000-00010.
5
The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT.恶性疾病所致上腔静脉综合征。多排螺旋CT成像
Eur J Radiol. 2006 Jul;59(1):93-103. doi: 10.1016/j.ejrad.2006.01.003. Epub 2006 Feb 14.
6
Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.支架置入术作为恶性上腔静脉综合征血管内治疗的首选方法。
AJR Am J Roentgenol. 2001 Sep;177(3):585-93. doi: 10.2214/ajr.177.3.1770585.
7
Bilateral subclavian vein thromboses presenting as a superior vena cava syndrome demonstrated by radionuclide blood flow and In-111 WBC imaging.放射性核素血流和铟 - 111白细胞显像显示双侧锁骨下静脉血栓形成表现为上腔静脉综合征。
Clin Nucl Med. 1995 Jul;20(7):630-2. doi: 10.1097/00003072-199507000-00015.
8
[Gianturco expandable metallic stents in the treatment of superior vena cava syndrome caused by lung cancer].[Gianturco可扩张金属支架治疗肺癌所致上腔静脉综合征]
Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Jun;30(6):1110-5.
9
Superior vena cava syndrome revisited.上腔静脉综合征再探讨。
Jpn J Clin Oncol. 1995 Apr;25(2):32-6.
10
Superior vena cava syndrome in small-cell lung cancer.小细胞肺癌中的上腔静脉综合征
Arch Intern Med. 1993 Feb 8;153(3):384-7.